Department of Neurosurgery, University of California, San Francisco, California 94143, USA.
J Neurosurg. 2010 Mar;112(3):479-90. doi: 10.3171/2009.6.JNS081161.
The authors discuss their method for placement of deep brain stimulation (DBS) electrodes using interventional MR (iMR) imaging and report on the accuracy of the technique, its initial clinical efficacy, and associated complications in a consecutive series of subthalamic nucleus (STN) DBS implants to treat Parkinson disease (PD).
A skull-mounted aiming device (Medtronic NexFrame) was used in conjunction with real-time MR imaging (Philips Intera 1.5T). Preoperative imaging, DBS implantation, and postimplantation MR imaging were integrated into a single procedure performed with the patient in a state of general anesthesia. Accuracy of implantation was assessed using 2 types of measurements: the "radial error," defined as the scalar distance between the location of the intended target and the actual location of the guidance sheath in the axial plane 4 mm inferior to the commissures, and the "tip error," defined as the vector distance between the expected anterior commissure-posterior commissure (AC-PC) coordinates of the permanent DBS lead tip and the actual AC-PC coordinates of the lead tip. Clinical outcome was assessed using the Unified Parkinson's Disease Rating Scale part III (UPDRS III), in the off-medication state.
Twenty-nine patients with PD underwent iMR imaging-guided placement of 53 DBS electrodes into the STN. The mean (+/- SD) radial error was 1.2 +/- 0.65 mm, and the mean absolute tip error was 2.2 +/- 0.92 mm. The tip error was significantly smaller than for STN DBS electrodes implanted using traditional frame-based stereotaxy (3.1 +/- 1.41 mm). Eighty-seven percent of leads were placed with a single brain penetration. No hematomas were visible on MR images. Two device infections occurred early in the series. In bilaterally implanted patients, the mean improvement on the UPDRS III at 9 months postimplantation was 60%.
The authors' technical approach to placement of DBS electrodes adapts the procedure to a standard configuration 1.5-T diagnostic MR imaging scanner in a radiology suite. This method simplifies DBS implantation by eliminating the use of the traditional stereotactic frame and the subsequent requirement for registration of the brain in stereotactic space and the need for physiological recording and patient cooperation. This method has improved accuracy compared with that of anatomical guidance using standard frame-based stereotaxy in conjunction with preoperative MR imaging.
作者讨论了他们使用介入性磁共振成像(iMR)进行深部脑刺激(DBS)电极放置的方法,并报告了该技术的准确性、初步临床疗效以及连续一系列丘脑底核(STN)DBS 植入治疗帕金森病(PD)的相关并发症。
使用颅骨安装的定向装置(美敦力 NexFrame)与实时磁共振成像(飞利浦 Intera 1.5T)结合使用。术前成像、DBS 植入和植入后的磁共振成像整合在一个单一的程序中,患者在全身麻醉状态下进行。植入的准确性通过两种测量方法进行评估:“径向误差”,定义为在连合下方 4 毫米的轴平面上,目标位置与导向鞘实际位置之间的标量距离;“尖端误差”,定义为期望的永久 DBS 导联尖端的前连合-后连合(AC-PC)坐标与导联尖端的实际 AC-PC 坐标之间的向量距离。临床结果采用未服药状态下的帕金森病统一评定量表第 III 部分(UPDRS III)进行评估。
29 例 PD 患者接受了 iMR 成像引导的 53 个 DBS 电极植入 STN。平均(+/- SD)径向误差为 1.2 +/- 0.65 毫米,平均绝对尖端误差为 2.2 +/- 0.92 毫米。尖端误差明显小于传统框架立体定向引导的 STN DBS 电极植入(3.1 +/- 1.41 毫米)。87%的导联通过单次脑穿透放置。磁共振图像上未见血肿。在系列早期发生了 2 例设备感染。在双侧植入的患者中,植入后 9 个月 UPDRS III 的平均改善率为 60%。
作者的 DBS 电极放置技术方法使该程序适应了放射科的标准配置 1.5T 诊断磁共振成像扫描仪。该方法通过消除传统立体定向框架的使用以及随后在立体定向空间中对大脑进行注册的要求,以及对生理记录和患者合作的要求,简化了 DBS 植入。与结合术前磁共振成像使用标准框架立体定向的解剖引导相比,该方法提高了准确性。